Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
65.35 MTWD
810.92 MTWD
15.37 M
Om TSH BIOPHARM CORPORATION LIMITED
Sektor
Bransch
VD
Ssu Yuan Yang
Webbplats
Huvudkvarter
Taipei
Grundat
2010
ISIN
TW0008432006
FIGI
BBG001QYZ3H1
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
